The Axis Study
Currently Recruiting
29 Nov 2026
Up to $2,950
Melbourne, Australia
Nonsense Mutation Recessive Dystrophic Epidermolysis Bullosa (NM-RDEB) is a rare inherited condition that affects the body’s ability to produce enough type VII collagen, a protein that helps keep skin strong and resilient.
This study includes a 2-night stay at the clinic and 6 follow-up visits and is evaluating a potential new treatment that may help address the underlying cause of the condition.
In this early-stage study, healthy volunteers will help researchers assess the medication’s safety, tolerability, and how it behaves in the body. The findings may support the development of future treatment options for people living with NM-RDEB.
Join our clinical trial
This is a first-in-human (FIH) study, meaning it is the first time the potential treatment is being tested in people. The study has been carefully designed with strict safety protocols and has been approved by an independent ethics committee. It is not known whether the study drug may cause unexpected, serious, or life-threatening side effects. While these are considered unlikely, you will be carefully monitored throughout the study and provided with prompt treatment if any such effects occur.Â
Before joining, you’ll receive detailed information about the study, meet with a doctor, and have the chance to ask any questions.Â
What to expect
- Participation in a monitored clinical environmentÂ
- Study visits scheduled Â
- Support from a professional medical teamÂ
- Reimbursement for your time and commitmentÂ
Study schedule
| Intake 1 | In-clinic stay:
29 November 2026 – 1 December 2026 |
Follow-up visits:
2 December 2026 – 13 December 2026 |
Study dates are subject to change. Our team will confirm details with you during the screening process.
Trial details
Study duration
- 2 nights stay
- 6 follow-up visits
Study medication
The study drug is administered as an oral capsule with water in a fasting state.
Additional eligibility
- Healthy Males and Females
- Weigh above 50.0kg and less than 100.0kgÂ
- Non-smokers (no tobacco or nicotine use for at least 1 month)Â
- Prescription medications must be complete 14 days prior to admission (with come exceptions)Â Â Â
- Willing to follow contraception guidelines (If applicable)Â Â
- Willing and able to attend all study visits and follow instructions  Â
Ethics
An independent ethics committee has approved this clinical trial.
Are you a match?
Age
18 - 55 years old
Remuneration
Up to $2,950 *with screening reimbursement.
Full details outlined in consent form.
Gender
Male, Female, Female (Post-menopausal) or Female of non-childbearing potential
BMI
BMI 18 - 32 kg/m2
Commitment
2 nights, 6 clinic visits
Medical condition
Not taking any medications